Utama › Kanser Paru-paru Bukan Sel Kecil › California › Newport Beach
Kajian klinikal Kanser Paru-paru Bukan Sel Kecil di Newport Beach, CA
14 kajian untuk Kanser Paru-paru Bukan Sel Kecil sedang mencari peserta di lokasi dalam dan sekitar Newport Beach (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
Mengambil pesertaFasa 3
- Hoag Hospital Newport Beach, Newport Beach
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
Mengambil pesertaFasa 1
- Research Site, Newport Beach
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
Mengambil pesertaFasa 3
- Hoag Memorial Hospital Presbyterian ( Site 0096), Newport Beach
Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors
Mengambil pesertaFasa 1
- Research Site, Newport Beach
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Mengambil pesertaKajian pemerhatian
- Hoag Memorial Hospital Presbyterian, Newport Beach
A Study of KK2269 in Adult Participants With Solid Tumors
Mengambil pesertaFasa 1
- Hoag Memorial Hospital Presbyterian, Newport Beach
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Mengambil pesertaFasa 3
- Hoag Memorial Hospital, Newport Beach
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
Mengambil pesertaFasa 1
- Hoag Family Cancer Institute, Newport Beach
Blood-brain Barrier (BBB) Opening Using Exablate Focused Ultrasound With Standard of Care Treatment of NSCLC Brain Mets
Mengambil pesertaFasa 3
- Hoag Memorial Hospital Presbyterian, Newport Beach
A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
Mengambil pesertaFasa 1/2
- Hoag Memorial Hospital Presbyterian, Newport Beach
Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers
Mengambil pesertaFasa 1/2
- Hoag Memorial Hospital Presbyterian, Newport Beach
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
Mengambil pesertaFasa 3
- Hoag Family Cancer Institute - Hoag Memorial Hospital, Newport Beach
Immunotherapy Biomarkers to Predict First-line PD(L)1-based Immunotherapy Response and Selection of Second-line Treatment in Stage IIIB-IV Non-small Cell Lung Cancer, IMMUNO-BIOMAP Trial
Mengambil pesertaFasa 2
- City of Hope at Newport Beach Fashion Island, Newport Beach
A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors
Mengambil pesertaFasa 1
- Hoag Memorial Hospital Presbyterian, Newport Beach
Kajian Kanser Paru-paru Bukan Sel Kecil di bandar lain
- Houston, TX145 kajian
- New York City, NY121 kajian
- Arlington, VA104 kajian
- Nashville, TN97 kajian
- Boston, MA90 kajian
- Los Angeles, CA87 kajian
- St. Louis, MO73 kajian
- Chicago, IL61 kajian
- Baltimore, MD60 kajian
- San Antonio, TX59 kajian
- Columbus, OH57 kajian
- Washington, DC55 kajian
Kajian lain di Newport Beach
- Kanser Payudara16 kajian
- Kanser Metastatik10 kajian
- COPD9 kajian
- Kanser Ovari9 kajian
- Kanser Endometrium7 kajian
- Kanser Paru-paru7 kajian
- Kanser Kolorektal6 kajian
- Kanser Prostat6 kajian
- Kanser Payudara Triple-Negatif6 kajian
- Kanser (semua jenis)6 kajian
- Karsinoma Sel Skuamosa Kepala dan Leher5 kajian
- Kanser Ginjal (Karsinoma Sel Renal)5 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.